Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Hypoplastic Left Heart Syndrome
100%
Pulmonary Artery
57%
Persistent Truncus Arteriosus
52%
Stent Placement
46%
Ductus Venosus
46%
Interatrial Septum
46%
Atrial Septal Defect
46%
Heterotaxy Syndrome
46%
Epilepsy in Children
46%
Heart Single Ventricle
46%
Anomalous Pulmonary Venous Connection
46%
Artery Bypass
46%
Percutaneous Transluminal Angioplasty
46%
Combination Therapy
46%
Hemostat
46%
Epileptic Seizure
30%
Cavopulmonary Connection
25%
Odds Ratio
23%
Lung Vascular Resistance
23%
Newborn Period
19%
Lung Artery Pressure
17%
Oxygen Saturation
17%
Norwood Procedure
17%
Anatomy
11%
Catheterization
11%
Cardiac Catheterization
11%
Lung Blood Flow
11%
ST Segment Depression
9%
Parental Stress
9%
microRNA 146a
7%
Patient with Epilepsy
7%
Multivariate Logistic Regression Analysis
7%
Heart Surgery
7%
Medical Record
7%
Retrospective Cohort Study
7%
Pediatrics Patient
7%
Disease
7%
Awareness
7%
Symptom
7%
Surgeon
7%
Population
7%
Thorax Surgery
7%
Portosystemic Anastomosis
6%
Liver Dysfunction
6%
Childbirth
6%
Pulmonary Vein Obstruction
6%
Vein Occlusion
6%
Liver Function
6%
Liver Enzyme
6%
In-Stent Restenosis
6%
Keyphrases
Pediatric Dilated Cardiomyopathy
46%
Heart Disease Risk Factors
46%
Infracardiac Total Anomalous Pulmonary Venous Connection
46%
Stepwise Treatment
46%
Perseus
46%
Restrictive Atrial Septum
46%
Balloon Angioplasty
46%
Right Ventricular
46%
Hypoplastic Left Heart Syndrome
46%
Pulmonary Flow
46%
Combination Therapy
46%
Pulmonary Artery
46%
Shunt
46%
Flow Management
46%
Norwood Palliation
19%
Catheter Balloon
17%
Cardiac Catheterization
13%
Pulmonary Vascular Resistance
13%
Pulmonary Blood Flow
13%
Nakata Index
13%
Coronary Artery Vasospasm
9%
ST Depression
9%
Vertical Vein
9%
On-pump Surgery
9%
Phase 1 Clinical Trial
9%
Rashkind
8%
Paracrine Mediators
6%
Exosome-derived microRNAs
6%
Safety Benefits
6%
MiR-146a-5p
6%
Preclinical Validation
6%
Translational Framework
6%
University Hospital
6%
Consecutive Patients
6%
No Significant Difference
6%
Okayama
6%
Cavopulmonary Shunt
6%
Shunt Flow
6%
Log-rank Test
6%
Pulmonary to Systemic Flow Ratio
6%
Systemic Vascular Resistance
6%
5-year Survival
6%
Treatment Strategy
6%
Mean Pulmonary Artery Pressure (mPAP)
6%
Improved Outcomes
6%
Ventricular End-diastolic Pressure
6%
Fontan
6%
Oxygen Saturation
6%
Seizure Characteristics
5%
Society of Thoracic Surgeons
5%